Variant report
Variant | esv2758795 |
---|---|
Chromosome Location | chr20:41252905-41277097 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs17748052 | chr20:41252905-41252906 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs377582771 | chr20:41252925-41252926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529842889 | chr20:41252944-41252945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs151119200 | chr20:41252960-41252961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs909862 | chr20:41252999-41253000 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
6 | rs909863 | chr20:41253081-41253082 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
7 | rs141079809 | chr20:41253083-41253084 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs372440622 | chr20:41253084-41253085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs909864 | chr20:41253127-41253128 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs80339474 | chr20:41253129-41253130 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs76264875 | chr20:41253133-41253134 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs189354510 | chr20:41253175-41253176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs181180360 | chr20:41253204-41253205 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs6130178 | chr20:41253215-41253216 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536801862 | chr20:41253224-41253225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556374683 | chr20:41253232-41253233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs150251213 | chr20:41253248-41253249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs145801490 | chr20:41253249-41253250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565593602 | chr20:41253250-41253251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs140628574 | chr20:41253271-41253272 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569648481 | chr20:41253272-41253273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560911686 | chr20:41253283-41253284 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138264874 | chr20:41253297-41253298 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549855007 | chr20:41253316-41253317 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs563188150 | chr20:41253350-41253351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs532354851 | chr20:41253379-41253380 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs78275479 | chr20:41253418-41253419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540029422 | chr20:41253424-41253425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs185826233 | chr20:41253438-41253439 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs534632223 | chr20:41253444-41253445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs6124478 | chr20:41253474-41253475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571213264 | chr20:41253486-41253487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs6030370 | chr20:41253498-41253499 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
34 | rs7262694 | chr20:41253517-41253518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs536213180 | chr20:41253523-41253524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs556621681 | chr20:41253540-41253541 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs576431506 | chr20:41253574-41253575 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs79689739 | chr20:41253585-41253586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs190494927 | chr20:41253586-41253587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs183098204 | chr20:41253593-41253594 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs565327563 | chr20:41253606-41253607 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs144943536 | chr20:41253687-41253688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs561523875 | chr20:41253730-41253731 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs78259214 | chr20:41253732-41253733 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543020699 | chr20:41253818-41253819 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs200292117 | chr20:41253823-41253824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565798470 | chr20:41253832-41253833 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563410434 | chr20:41253834-41253835 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532145603 | chr20:41253856-41253857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs538902006 | chr20:41253899-41253900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Gastric cancer | 17908304 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Autism | 22495311 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 21693616 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Astrocytoma | 17387387 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
colon cancer | 17210682 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 22028636 | CNVD |
Breast cancer | 21264507 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Soft tissue tumor | 16732325 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Gastric cancer | 17167181 | CNVD |
Myeloproliferative neoplasm | 19047681 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Bladder cancer | 21909424 | CNVD |
Breast cancer | 17603634 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Breast cancer | 21364760 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Oral cancer | 21386901 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Ovarian cancer | 19193619 | CNVD |
Breast cancer | 21785460 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 18628472 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Prostate cancer | 18632612 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Gastric cancer | 16891809 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cervical cancer | 21062161 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Gastric cancer | 20585902 | CNVD |
Ductal carcinoma | 18381933 | CNVD |
Cancer | 21129771 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 20864512 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:41251400-41253800 | Enhancers | NHEK | skin |
2 | chr20:41251600-41253600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
3 | chr20:41253600-41270200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr20:41257000-41258200 | Enhancers | Liver | Liver |
5 | chr20:41263000-41263400 | Enhancers | HUES64 Cell Line | embryonic stem cell |
6 | chr20:41263000-41264200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr20:41270200-41270800 | Enhancers | Pancreas | Pancrea |
8 | chr20:41270200-41271600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
9 | chr20:41271600-41300800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
10 | chr20:41277000-41277400 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |